Literature DB >> 32365740

Reply to "Comment on: Effects of Nigella Sativa on Type-2 Diabetes Mellitus: A Systematic Review".

Amiza Hamdan1, Ruszymah Haji Idrus1, Mohd Helmy Mokhtar1.   

Abstract

Thank you for your interest and the comments [1] on our review article "Effects of Nigella Sativa on Type-2 Diabetes Mellitus: A Systematic Review" [2]; we believe research into natural products needs to be supported, as they are at the forefront of drug discovery [...].

Entities:  

Year:  2020        PMID: 32365740      PMCID: PMC7246921          DOI: 10.3390/ijerph17093111

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


Thank you for your interest and the comments [1] on our review article “Effects of Nigella Sativa on Type-2 Diabetes Mellitus: A Systematic Review” [2]; we believe research into natural products needs to be supported, as they are at the forefront of drug discovery. According to the guidelines, at least two databases were required to retrieve all included studies [3]. In this review, two databases, Scopus and Medline via Ebscohost, have been used to identify relevant studies about the reported effect of Nigella sativa (NS) on type-2 diabetes mellitus (T2DM), which in line with the guidelines. We also had restricted the selection of articles to only original articles that were published in English in order to avoid misinterpretation of non-English language articles. The guidelines on including articles in languages other than English are still lacking. In addition, it is costly and time-consuming to include non-English articles due to the lack of language resources to translate these articles [4]. Most aspects of this review are reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement guidelines. However, the protocol of this review is not registered in the database of systematic review protocols. Finally, thank you for the comments and we will take note for our future reviews.
  4 in total

1.  From English to Chinese, Japanese, and Russian: extending research visibility with language translations of a conference slide presentation.

Authors:  Lilian Hoffecker; Dana Abbey
Journal:  J Med Libr Assoc       Date:  2017-01

2.  AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.

Authors:  Beverley J Shea; Barnaby C Reeves; George Wells; Micere Thuku; Candyce Hamel; Julian Moran; David Moher; Peter Tugwell; Vivian Welch; Elizabeth Kristjansson; David A Henry
Journal:  BMJ       Date:  2017-09-21

3.  Comment on: Effects of Nigella Sativa on Type-2 Diabetes Mellitus: A Systematic Review.

Authors:  Sherif T S Hassan; Miroslava Šudomová
Journal:  Int J Environ Res Public Health       Date:  2020-03-03       Impact factor: 3.390

Review 4.  Effects of Nigella Sativa on Type-2 Diabetes Mellitus: A Systematic Review.

Authors:  Amiza Hamdan; Ruszymah Haji Idrus; Mohd Helmy Mokhtar
Journal:  Int J Environ Res Public Health       Date:  2019-12-05       Impact factor: 3.390

  4 in total
  2 in total

1.  TaibUVID nutritional supplements help rapid cure of COVID-19 infection and rapid reversion to negative nasopharyngeal swab PCR: for better public prophylaxis and treatment of COVID-19 pandemic.

Authors:  Salah Mohamed El Sayed; Moutasem Salih Aboonq; Yasmeen Talal Aljehani; Mohammad Ahmad Hassan; Rabab M Abou El-Magd; Abdelrahman I Abdelrahman; Rehab El-Tahlawi; Manal Mohamed Helmy Nabo; Reda S Yousef; Ahmed Alamir Mahmoud; Yasser Yahia Elsayed; Mostafa Abu-Elnaga; Tamer M Soliman; Abdelhady Ragab Abdel-Gawad; Momen Elshazley; Hussam Baghdadi; Samer El-Sawy; Hany Salah Mahmoud; Mariam E El-Anzi; Mansour Barakah Alharbi
Journal:  Am J Blood Res       Date:  2020-12-15

Review 2.  Nigella sativa L. Phytochemistry and Pharmacological Activities: A Review (2019-2021).

Authors:  Mohammed Dalli; Oussama Bekkouch; Salah-Eddine Azizi; Ali Azghar; Nadia Gseyra; Bonglee Kim
Journal:  Biomolecules       Date:  2021-12-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.